EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Development of an experimental animal model for the protection test of Haemophilus pleuropneumoniae vaccine






Nihon Juigaku Zasshi. Japanese Journal of Veterinary Science 47(2): 269-273

Development of an experimental animal model for the protection test of Haemophilus pleuropneumoniae vaccine

Protective effect of an inactivated vaccine prepared from H. pleuropneumoniae (Hpn) serotype 2 strains was investigated. About 80% of the guinea pigs injected i.m. with the Hpn vaccines survived the i.p. (IP) or intratracheal (IT) challenge exposure with the homologous strains. The survived animals had at least 1:16 of the complement-fixation (CF) antibody titers. The challenge-exposed organisms were completely cleared from the various tissues and organs of the survivals, and their lungs appeared to be normal. All the dead guinea pigs which had less than 1:16 of the CF titers showed severe extensive hemorrhagic lesions in the lungs, and numerous organisms were recovered from the lung, the heart blood, and the peritoneal fluid of each dead guinea pig. Protective potency of the Hpn vaccine could be estimated by the surviving rate of the injected guinea pigs, in addition to this, the protection rate significantly correlated to the level of the CF antibody titers. There were no differences in protection rate either among the 5 challenge strains or between the IP and IT exposure routes. Guinea pigs, instead of pigs, might possibly be applicable as a suitable experimental model for evaluating protective potency of the Hpn vaccine.


Accession: 005132429

PMID: 4010126

DOI: 10.1292/jvms1939.47.269



Related references

Pangerl, R.; Flatscher, J.; Schweighardt, H.; Werner Tutschku, V.; Jahn, J., 1986: Efficacy of an autogenous Actinobacillus (Haemophilus) pleuropneumoniae vaccine in a swine fattening test centre. Pleuropneumonia occurring at a testing station was associated with type 2 A. pleuropneumoniae. A vaccine prepared from three selected, local strains prevented pneumonia in 237 pigs (compared with 12 cases among 237 unvaccinated pigs). There was le...

Anonymous, 1987: Pleuropneumonia caused by haemophilus pleuropneumoniae equals haemophilus parahaemolyticus in swine v experiments for a efficacious vaccine

Kielstein, P., 1981: Immunoprophylaxis of experimental Haemophilus pleuropneumoniae infection in a miniature pig immunization model. An infection and immunization model of the infection, using SPF LEWE miniature pigs, was developed. Various immunogenic strains were selected, and several vaccines were tested for efficacy, using a calculated activity index, and a comparison of lu...

Markowska-Daniel, I.; Pejsak, Z.; Szmigielski, S.; Sokolska, G.; Jeljaszewicz, J.; Pulverer, G., 1992: Adjuvant properties of Propionibacterium avidum KP-40 in vaccination against endemic viral and bacterial infections. II. Swine immunized with inactivated Haemophilus pleuropneumoniae vaccine and experimentally infected with different virulent serotypes of H. pleuropneumoniae. Forty 3-month old swine were treated with immunomodulating Propionibacterium avidum KP-40 (PA) and/or vaccinated with a formalin-inactivated mixture of serotypes 1, 3, 5 and 9 of Haemophilus pleuropneumoniae (Pleurovac). Three weeks after revaccin...

Markowska Daniel, I.; Pejsak, Z.; Szmigielski, S.; Sokolska, G.; Jeljaszewicz, J.; Pulverer, G., 1992: Adjuvant properties of Propionibacterium avidum KP-40 in vaccination against endemic viral and bacterial infections. II. Swine immunized with inactivated Haemophilus pleuropneumoniae vaccine and experimentally infected with different virulent serotypes of H. pleuropneumoniae. Forty 3-month old swine were treated with immunomodulating Propionibacterium avidum KP-40 (PA) and/or vaccinated with a formalin-inactivated mixture of serotypes 1, 3, 5 and 9 of Haemophilus pleuropneumoniae (Pleurovac). Three weeks after revaccin...

Mitui, T.; Onaga, H.; Nagasawa, Y.; Nomura, Y.; Kuramasu, S., 1981: Haemophilus infection in swine 1. application of the latex agglutination test for the diagnosis of haemophilus pleuropneumoniae haemophilus parahaemolyticus infection. A latex agglutination test was evaluated as a method for the detection and titration of antibodies against swine Haemophilus infection. The test is evidently applicable to the etiologic diagnosis of Haemophilus infection in swine. In swine infecte...

Gunnarsson A., 1979: Evaluation of different antigens in the complement fixation test for diagnosis of haemophilus pleuropneumoniae haemophilus parahaemolyticus infections in swine. The identification of new serotypes of H. pleuropneumoniae (parahaemolyticus) and the frequency of pleural adhesions due to contagious pleuropneumonia in many fattening swine herds have prompted the study of the complement-fixation (CF) test as a...

Dunkley M.L.; Cripps A.W.; Reinbott P.W., 1991: Development of an animal model to test a helicobacter pylori vaccine. Microbial Ecology in Health & Disease 4(SPEC ISSUE): S148

Mores, N.; Souza, J.C. de A.; Nogueira, R.H.G., 1984: Experimental study of pleuropneumonia caused by Haemophilus (Actinobacillus) pleuropneumoniae in swine. I. Pathogenicity and development of lesions. A Brazilian isolate of serotype 5 was inoculated into the nose of 16 pigs aged 10-13 weeks. Illness commenced within 6 h. In pigs killed 24 h after infection there were signs of a circulatory disorder in the lungs, with oedematous haemorrhages and...

Udeze, F.A., 1988: Role of virulence determinants of Haemophilus pleuropneumoniae in the pathogenesis of porcine Haemophilus pleuropneumoniae. Sequential examination of histological lesions induced by purified lipopolysaccharide (LPS), heat-treated and non-heat-treated cell-free culture supernatant (CFCS) fluid obtained from A. pleuropneumoniae growth culture showed that endotoxin was re...